IBDEI2KN ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,43633,0)
 ;;=C49.9^^167^2085^51
 ;;^UTILITY(U,$J,358.3,43633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43633,1,3,0)
 ;;=3^Malig Neop Connective & Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,43633,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,43633,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,43634,0)
 ;;=E11.9^^167^2085^19
 ;;^UTILITY(U,$J,358.3,43634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43634,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,43634,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,43634,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,43635,0)
 ;;=E10.9^^167^2085^18
 ;;^UTILITY(U,$J,358.3,43635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43635,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,43635,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,43635,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,43636,0)
 ;;=D50.0^^167^2085^48
 ;;^UTILITY(U,$J,358.3,43636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43636,1,3,0)
 ;;=3^Iron Deficiency Anemia d/t Blood Loss
 ;;^UTILITY(U,$J,358.3,43636,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,43636,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,43637,0)
 ;;=D62.^^167^2085^6
 ;;^UTILITY(U,$J,358.3,43637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43637,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,43637,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,43637,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,43638,0)
 ;;=D64.9^^167^2085^8
 ;;^UTILITY(U,$J,358.3,43638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43638,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,43638,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,43638,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,43639,0)
 ;;=F03.90^^167^2085^17
 ;;^UTILITY(U,$J,358.3,43639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43639,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturb,Unspec
 ;;^UTILITY(U,$J,358.3,43639,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,43639,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,43640,0)
 ;;=G30.9^^167^2085^7
 ;;^UTILITY(U,$J,358.3,43640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43640,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,43640,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,43640,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,43641,0)
 ;;=I10.^^167^2085^43
 ;;^UTILITY(U,$J,358.3,43641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43641,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,43641,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,43641,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,43642,0)
 ;;=G45.9^^167^2085^66
 ;;^UTILITY(U,$J,358.3,43642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43642,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,43642,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,43642,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,43643,0)
 ;;=K85.9^^167^2085^5
 ;;^UTILITY(U,$J,358.3,43643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43643,1,3,0)
 ;;=3^Acute Pancreatitis,Unspec
 ;;^UTILITY(U,$J,358.3,43643,1,4,0)
 ;;=4^K85.9
 ;;^UTILITY(U,$J,358.3,43643,2)
 ;;=^5008887
 ;;^UTILITY(U,$J,358.3,43644,0)
 ;;=N18.4^^167^2085^14
 ;;^UTILITY(U,$J,358.3,43644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43644,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,43644,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,43644,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,43645,0)
 ;;=R40.3^^167^2085^57
 ;;^UTILITY(U,$J,358.3,43645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,43645,1,3,0)
 ;;=3^Persistent Vegetative State
 ;;^UTILITY(U,$J,358.3,43645,1,4,0)
 ;;=4^R40.3
 ;;^UTILITY(U,$J,358.3,43645,2)
 ;;=^5019434
 ;;^UTILITY(U,$J,358.3,43646,0)
 ;;=R44.3^^167^2085^38
